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Abstract
Background: To understand why treatment referral rates for ESRF are lower in Ireland than in
other European countries, an investigation of factors influencing general practitioner referral of
patients developing ESRF was conducted.
Method:  Randomly selected general practitioners (N = 51) were interviewed using 32
standardised written patient scenarios to elicit referral strategies. Main outcome measures:
General practitioner referral levels and thresholds for patients developing end-stage renal disease;
referral routes (nephrologist vs other physicians); influence of patient age, marital status and co-
morbidity on referral.
Results: Referral levels varied widely with the full range of cases (0–32; median = 15) referred by
different doctors after consideration of first laboratory results. Less than half (44%) of cases were
referred to a nephrologist. Patient age (40 vs 70 years), marital status, co-morbidity (none vs
rheumatoid arthritis) and general practitioner prior specialist renal training (yes or no) did not
influence referral rates. Many patients were not referred to a specialist at creatinine levels of 129
µmol/l (47% not referred) or 250 µmol/l (45%). While all patients were referred at higher levels
(350 and 480 µmol/l), referral to a nephrologist decreased in likelihood as scenarios became more
complex; 28% at 129 µmol/l creatinine; 28% at 250 µmol/l; 18% at 350 µmol/l and 14% at 480 µmol/
l. Referral levels and routes were not influenced by general practitioner age, sex or practice
location. Most general practitioners had little current contact with chronic renal patients (mean
number in practice = 0.7, s.d. = 1.3).
Conclusion: The very divergent management patterns identified highlight the need for guidance
to general practitioners on appropriate management of this serious condition.
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Background
Historically, the provision of renal replacement therapy
for end-stage renal disease in Ireland (57.8 new cases per
million population in 1994) [1] has been lower than the
internationally recommended rate (80 per million popu-
lation)[2]. Moreover recent data suggests that while Ire-
land compares favorably with European averages in
regard to Transplant treatment (353 per million popula-
tion versus EU average 185 per million population), Irish
dialysis rates [3] still lag behind the European average
[4](303 per million population versus EU average of 400
per million population). This all suggests that Irish treat-
ment rates may indicate under-referral of patients with
end-stage renal disease. Increases in treatment rates in the
United Kingdom [5] have been achieved by increasing
referrals of appropriate cases from primary care services. A
number of factors may influence referral rates. In a stand-
ardised case study (with co-morbidity held constant),
Canadian physicians referred significantly fewer older
patients [6]. In a similar study format, British general prac-
titioners referred fewer end-stage renal disease patients
when compared with British nephrologists [7]. The issue
of under-referral may be compounded by late referral
which also represents an important element of the referral
process. For example, a survey in Canada, the United
States and the UK showed that family physicians referred
patients at a serum creatinine of between 260 and 340
mmol/L regardless of patient age, whereas most nephrol-
ogists would prefer to accept referrals at lower serum cre-
atinines [8]. For example, the guidelines of the UK Renal
Association [9] indicate that all patients with a creatinine
between 150–200 mmol/L should be referred to a special-
ist. Similarly, a European study investigating the optimal
time for a first referral to a nephrologist found substantial
differences between diabetes experts and nephrologists
[10].
Under-referral or late referral has important healthcare
management implications. Ultimately, the consequences
of late referral of patients includes increased mortality and
morbidity [11], increased cost and duration of hospitali-
zation [12], increase need for urgent dialysis [13] and
reduced access to renal transplantation services [14]. A
recent review of the literature [15] concluded that late
referral leads to suboptimal management of complica-
tions of chronic renal insufficiency, and thus increased
morbidity and mortality of patients on renal replacement
therapy.
The aim of this study was to examine decision-making
strategies of general practitioners regarding referral for
renal replacement therapy in order to provide informa-
tion on clinical, demographic and service-related factors
influencing levels and patterns of referral. Since episodes
of patients developing renal failure presenting in general
practice are relatively rare, standardised case analysis was
used as the method of examining what is likely to happen
in actual general practice. Provided that realistic cases are
constructed, such written simulations are regarded as suit-
able for measuring clinical judgements and elucidating
the decision making process [16,17]. For instance, stand-
ardised case analysis has been demonstrated to be an
acceptable method of approximating actual clinical prac-
tice for general practitioners (respiratory illness [18] and
gastroenteritis [19]) and for specialists (rheumatologists
[20]). The main outcomes measures were general practi-
tioner referral levels, thresholds for patients developing
end-stage renal disease, referral routes and influence of
patient age, marital status and co-morbid condition on
referral.
Method
General practitioners were randomly selected from an
urban and a rural setting. The rural setting was selected to
represent typical general practice distances from a major
renal centre. Members of the Irish College of General Prac-
titioners were invited by letter and follow-up telephone
call to take part in an interview study. Following this, each
participating GP was visited by the first author who con-
ducted a structured interview using the standardized case
developed by the researchers.
A total of 79 general practitioners were randomly identi-
fied from area listings. Eight general practitioners were
unable to take part as they were on holiday during the
research period. A further 6 general practitioners could
not be contacted by phone. Of 31 urban general practi-
tioners contacted 25 participated in the study (81%
response rate), while 26 of the 27 rural general practition-
ers participated (96% response rate).
Interviews comprised two parts
a) Case scenarios depicting patients in varying stages of
renal failure presenting in general practice. Cases were
developed by a general practitioner and nephrologist.
They comprised clinical information representing a 'mod-
erate' and 'severe' renal failure profile. Cases were devel-
oped as a series of successive general practitioner
consultations with laboratory investigation outcomes
available where requested. Moderate cases comprised of a
patient presenting with symptoms which are associated
with relatively low initial creatinine level; 129 µmol/l
increasing to 350 µmol/l after a second visit. Equivalent
levels in the severe scenarios were 250 µmol/l and 480
µmol/l. Cases also differed in demographic and co-mor-
bidity criteria – age of patient (40 vs 70 years), marital sta-
tus (single vs married) and co-morbidity (inactive
rheumatoid arthritis vs no co-morbidity). This design pro-
vided 32 case combinations (see example, fig. 1).BMC Health Services Research 2006, 6:114 http://www.biomedcentral.com/1472-6963/6/114
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Standardised patient scenario Figure 1
Standardised patient scenario.BMC Health Services Research 2006, 6:114 http://www.biomedcentral.com/1472-6963/6/114
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b) Questions on general practitioner demographic profile
and training and current experience with renal disease.
Results
General practitioners (43 men/8 women) averaged 50
years old (s.d. = 9) with a mean practice size of 2.3 (s.d. =
2.3) partners. Practices were located a median of 15 miles
(range = 1–65) from the nearest dialysis centre. General
practitioners reported little current contact with renal
patients; 90% of general practitioners had ≤ 1 hemodialy-
sis, 96% had ≤ 1 continuous ambulatory peritoneal dialy-
sis and 79% had ≤ 1 transplant patients in their practice.
Figure 2 outlines general practitioner referral routes by
level of creatinine. While almost all patients were referred
at higher levels (350 and 480 µmol/l), referral to a neph-
rologist decreased in likelihood as the scenarios became
more complex, including having higher creatinine levels.
The majority of patients (99%) were referred to a special-
ist at some point; 46% were referred after the first set of
laboratory test results were available. Most were referred
to either a nephrologist or a general physician (table 1).
There was no age difference in referral patters with older
patients referred as often to a nephrologist as younger
patients (chi-square = 0.73), similarly there were no refer-
ral rate difference between severe cases and moderate
cases (chi-square = 1.30).
Referral levels varied widely with the full range of cases
(0–32; median = 15) referred by different general practi-
tioners after first laboratory results were available. Referral
rates did not differ by general practitioner according to
sex, practice size or current experience with renal patients.
One-way analysis of variance indicated a significant inter-
action between general practitioner training experiences
and referral rates; (a) general practitioners who had
trained on a renal team (14% of general practitioners), (b)
general practitioners who had no specific renal experience
in training (60%) and (c) general practitioners who, while
not training on a renal team, had some hospital experi-
ence with renal patients (26%). Scheffe post hoc compar-
isons indicated no significant differences between GPs
with differing experiences.
Conclusion
Previous studies have examined reported referral levels to
consultants [8,9], but have not focused on differences
across general practitioners in their reported referral strat-
egies. Referral across the complete range of cases pre-
sented, with no influence of age, marital status or clinical
severity, illustrates that no consensus exists about an opti-
mal referral strategy. Such a result is consistent with simi-
lar vignette-based research that found substantial
variation in dialysis decision making among consultant
nephrologists in Northern Ireland [21].
The practical implications of this study can be best under-
stood with regard to, firstly, referral to any specialist and
secondly, referral to a nephrologist. The first key issue is
whether GPs referred for further investigation. Study find-
ings indicate under-referral of cases for specialist attention
by general practitioners in the light of significant renal
impairment. Neither general practitioner nor patient char-
acteristics influenced referral. The lack of influence of
patient factors is encouraging given evidence that older
age and co-morbidity have been inappropriately associ-
ated with lower rates of referral [22]. However creatinine
levels of 250 µmol/l (case 2) are approaching chronic
renal failure levels (≥ 300 µmol/l) [23] yet only 55% of
these cases would be referred on to any specialist
The second point of interest concerns whether GPs
referred to a nephrologist. Referral to a nephrologist
decreased in likelihood as the scenarios became more
complex. The imperative to tackle late referral is under-
lined by estimates that suggest that 25% to 50% of
patients worldwide who commence renal replacement
therapy are referred late to a nephrology service [23]. Early
referral helps to optimize health care use and patient man-
agement [15], and enables the identification of patients at
Table 1: General practitioner referral patterns for standardised patient cases indicating development of end-stage renal failure
Patient characteristic Specialist Referral by GP
Nephrologist % General Physician % Urologist % Other %
All cases 44 37 7 11*
Younger patient (age 40) 47 36 7 10
Older patient(age 70) 41 39 7 13
Moderate symptoms 40 42 6 12
Severe symptoms 48 32 8 12
*1% of patients not referred to specialists; Moderate symptoms = 129 to 350 µmol/l creatinine, Severe symptoms = 250 to 480 µmol/l creatinineBMC Health Services Research 2006, 6:114 http://www.biomedcentral.com/1472-6963/6/114
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General practice referral routes by creatinine level Figure 2
General practice referral routes by creatinine level.BMC Health Services Research 2006, 6:114 http://www.biomedcentral.com/1472-6963/6/114
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risk of rapid deterioration in renal function and/or com-
plications such as anemia, hypertension and cardiovascu-
lar disease.
It is worth noting that active management of renal failure
by dialysis is a medical innovation of the latter half of the
twentieth century. Many of the GPs studied may not have
experienced an active approach to dialysis in training.
Low numbers of nephrologists available (10 in 1996 in
Ireland) may also have influenced referral strategies.
Accepting the limitations of research using 'paper-case'
scenarios and reported behaviours, the study did find a
pattern of under-referral and/or late-referral for advanced
renal failure. This reported practice is consistent with a
reported patient referral rate in Ireland. While published
guidelines advocate early diagnosis and prompt treatment
of renal disease [2], it is not clear at what point direct refer-
ral to a nephrologist is the most efficient management
strategy for patients with renal difficulties. What is clear
from reported practice in this study is that a significant
proportion of patients presenting with symptoms of
chronic renal failure would not be referred to a specialist.
The very divergent management patterns identified across
practitioners highlights the need for guidance to general
practitioners on appropriate management including refer-
ral criteria, referral thresholds and appropriate referral
routes. One potential way to promote earlier referral of
patients with chronic renal failure is the adoption of the
glomerular filtration rate (GFR) as a measurement of kid-
ney function. This new classification of kidney disease,
launched by the American Kidney Foundation [24], is
based on estimated GFR calculated from serum creatinine,
age and sex. This is in many countries now being reported
directly to primary care, and is considered a better indica-
tor for detecting poor renal function than is serum creati-
nine on its own [25]. Ongoing monitoring of general
practitioner referral patterns is needed to ensure that such
developments translate into appropriate referral from pri-
mary care for this serious but manageable medical condi-
tion.
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